secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001801170-24-000082
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health resolves derivative suits; $2.5M counsel fees, governance changes
-------------------------------------------------------------------------------

- Settlement requires no monetary payment to shareholders; $2.5M in fees to plaintiffs' counsel subject to court approval.
- Company must implement corporate governance enhancements as part of settlement.
- Court preliminarily approved settlement on March 5, 2024; final approval hearing set for July 11, 2024.
- Derivative actions stemmed from Hindenburg Research allegations and 2021 de-SPAC merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000082/0001801170-24-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117024000082/clov-20240404.htm
  HTML page:      https://secwatch.observer/filing/0001801170-24-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer